new glp 1 med Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a study finds GLP-1s: What They Are and

There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial

These tools, combined with a medically supervised program, create a comprehensive approach to your health

Proteoglycan peptides and MITF expression: New research shows measurable MITF recovery in human melanocytes with disrupted Wnt signalling

#PharmaIndustry #CDSCO #DrugRegulation #GLP1 #HealthcarePolicy #Pharmaceuticals #ObesityTreatment #Diabetes #CaseStudy To view or add a comment, sign in The Central Drugs Standard Control Organization (CDSCO) has recently issued an advisory restricting direct and surrogate advertising of GLP-1 receptor agonists, a class of prescription drugs that has gained considerable attention in the context of weight-loss therapies